Ann: Appendix 3Y - Dr Daniel Tillett, page-34

• Totally agree with this.

But my worry has shifted from
Am I confident in the signs that this drug works, and that will become widely used in cancer treatment (leading to a buyout)?

to:
It seems very possible to have a super duper cancer drug worth billions that may even get bought out, but never achieves the share price it should. (Like many, or even most, people here I am seriously hoping for a few bags from this haha)

And it seems like it could all be done by 2023, or if not 2024. So the current low market cap is a real worry.

Plus
Bear markets
Covid delays
Australian not being a great place for biotech investments

Im not selling a single share but I’m more doubtful than I was.

If RAC proves itself as an effective drug, how likely is it that will lead to a big pharma bidding war?

Seems logical, but sometimes the way big money works is surprising and even corrupt to me.